View PDF VersionPrevious ArticleNext Article

Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence
DOI: 10.1039/C6MD90009G (Correction) Med. Chem. Commun., 2016, 7, 562-562

Correction: eCF309: a potent, selective and cell-permeable mTOR inhibitor

Craig Fraser , Neil O. Carragher and Asier Unciti-Broceta *
Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK. E-mail: Asier.Unciti-Broceta@igmm.ed.ac.uk

Received 22nd February 2016 , Accepted 22nd February 2016

First published on 29th February 2016

Abstract

Correction for ‘eCF309: a potent, selective and cell-permeable mTOR inhibitor’ by Craig Fraser et al., MedChemComm, 2016, DOI: 10.1039/c5md00493d.

The authors regret an error in their manuscript. In the first sentence of the third paragraph of the Results and discussion section ‘HER2-positive MCF7 cells’ should be replaced by ‘ER-positive MCF7 cells’.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

This journal is © The Royal Society of Chemistry 2016